The Role of Selective Laser Trabeculoplasty in the Management of Primary Open-angle Glaucoma

Aim: underlining the benefits of the Selective laser trabeculoplasty (SLT) in the management of glaucoma

Study: Selective laser trabeculoplasty (SLT) is a Laser used to treat open-angle glaucoma. A prospective, monocentric study was carried out over a period of 8 months. 34 eyes which benefited from a session of SLT. The intra ocular pression (IOP) was measured just before the laser, on the 7th day, then at one month, at the 3rd and finally at the 6th month. Success was defined as a decrease in IOP at 6 months ≥ 20% from baseline. As result, the mean pressure drop was 1.7mmHg, 3.15mmHg, 4.49mmHg and 5.97mmHg at day 7, month 1, month 3 and month 6 respectively. The success rate was 61.7%. Factors for a good response to SLT in our series included the absence of diabetes and, high baseline IOP. Other factors such as age, sex, race, hypertension, myopia, central corneal thickness, and the number of hypotonising eye drops used do not seem to be correlated with the success of SLT.